Assessments of Progress and Claims
Commentators are critically evaluating corporate trajectories, including challenges facing major company strategies and optimistic medical breakthrough timelines. Discussions also explore the development of autonomous researchers alongside skepticism regarding imminent industry milestones.
Independent evaluation of industry claims helps keep expectations grounded amidst high commercial enthusiasm.
Source posts · 4
Google’s biggest mistake? — A theory about what went wrong, and some open questions about what might happen next
Gary Marcus analyzes Google's strategic mistakes and discusses open questions about the company's future.
No, Dario Amodei, we will not be curing cancer and “most human disease” in five to ten years — What Amodei left out
Gary Marcus disputes Dario Amodei's claim that AI will cure cancer and most human diseases within five to ten years.
Import AI 469: Science AI; RSI simulator; and Zuck's technological pessimism — The new frontier of AI is developing capable autonomous researchers
The latest Import AI newsletter discusses the development of autonomous AI researchers, scientific AI, and technological pessimism.